On July 9, 2025, HeartSciences Inc. amended its Equity Incentive Plan to increase the number of shares available for issuance to 1,000,000 and awarded restricted stock units and stock options to executives, including 68,750 RSUs to CEO Andrew Simpson. The company has raised $1.7 million from its $15 million Reg A Offering, issuing 487,701 units, and has converted some preferred stock into common shares, totaling 1,555,049 shares outstanding.